What it is
Dihexa is a synthetic hexapeptide developed at Washington State University. Derived from angiotensin IV but engineered for c-Met binding rather than AT4/IRAP.
Evidence snapshot
Category: Cognition. Status: Preclinical. See the references section below for the underlying primary sources.
Mechanism
Potently activates the c-Met receptor (the HGF receptor), triggering downstream signalling that promotes synaptic plasticity, dendritic spine formation, and neuronal survival.
Key research findings
In rodent models, dihexa enhances learning and memory, including in models of cognitive decline and traumatic brain injury.
Limits of the evidence
Very limited published work. Mechanism specificity needs more characterisation. Off-label use in nootropic contexts is widespread